IHI - ETF AI Analysis
Top Page
iShares U.S. Medical Devices ETF (IHI)
Rating:74Outperform
Price Target:―
Positive Factors
Focused Exposure to Medical Devices
The fund gives targeted access to U.S. medical device companies, allowing investors to benefit if this specialized area of health care recovers.
Large, Established Companies in Top Holdings
Many of the biggest positions are well-known, mature health care businesses, which can offer more stability than smaller, unproven firms.
Meaningful Asset Base
The ETF manages several billion dollars in assets, suggesting it is widely used by investors and likely to remain available and tradable.
Negative Factors
Recent Weak Performance
The fund has shown weak returns so far this year and in recent months, which may concern investors looking for near-term strength.
High Concentration in a Few Stocks
A small number of holdings make up a large share of the portfolio, so poor results from these companies can strongly affect the ETF.
Single-Sector, U.S.-Only Focus
Almost all of the fund is invested in U.S. health care stocks, offering little diversification across sectors or countries.
IHI vs. SPDR S&P 500 ETF (SPY)
AUM3.19B
RegionNorth America
Expense Ratio0.38%
Beta0.65
IssueriShares
Inception DateMay 01, 2006
Dividend Yield0.44%
Asset ClassEquity
Index TrackedDJ US Select / Medical Equipment
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,990,098
30 Day Avg. Volume2,433,463
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
64.93Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering46
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IHI Summary
IHI is the iShares U.S. Medical Devices ETF, which follows the DJ US Select / Medical Equipment index. It invests in U.S. companies that make medical devices and equipment used in surgeries, diagnostics, and patient care. Well-known holdings include Abbott Laboratories and Intuitive Surgical. Someone might invest in IHI to tap into the long-term growth of healthcare technology while spreading risk across many companies instead of picking a single stock. A key risk is that it is heavily focused on one sector, so its price can rise or fall sharply with changes in the healthcare and medical device industry.
How much will it cost me?The iShares U.S. Medical Devices ETF (IHI) has an expense ratio of 0.38%, which means you’ll pay $3.80 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is a sector-focused fund, which typically involves more specialized management compared to broad-market passive funds.
What would affect this ETF?The iShares U.S. Medical Devices ETF (IHI) could benefit from growing demand for advanced healthcare solutions and technological innovations in medical devices, driven by an aging population and increased focus on personalized medicine. However, potential risks include regulatory changes, pricing pressures, and economic downturns that may impact healthcare spending, as well as competition among top holdings like Abbott Laboratories and Intuitive Surgical. The ETF’s focus on U.S.-based companies may also limit exposure to growth opportunities in international markets.
IHI Top 10 Holdings
IHI is a pure play on U.S. medical devices, and its story right now is about a few heavyweights losing steam at the same time. Abbott and Intuitive Surgical sit at the top of the portfolio, but both have been lagging lately, turning what should be growth engines into mild headwinds. Stryker and Medtronic are also soft, adding to the drag rather than lifting returns. Even Boston Scientific, another key name, has been under pressure. With nearly all exposure in U.S. healthcare equipment, the fund is highly concentrated in one sector and a handful of big operators.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Intuitive Surgical | 16.38% | $501.05M | $159.03B | -18.96% | 78 Outperform | |
| Abbott Laboratories | 15.66% | $479.17M | $153.94B | -33.25% | 73 Outperform | |
| Stryker | 10.83% | $331.31M | $123.25B | -17.12% | 70 Outperform | |
| Edwards Lifesciences | 4.99% | $152.75M | $47.77B | 11.24% | 79 Outperform | |
| Becton Dickinson | 4.82% | $147.38M | $40.49B | -15.12% | 67 Neutral | |
| Idexx Laboratories | 4.74% | $144.95M | $43.67B | 9.56% | 78 Outperform | |
| Medtronic | 4.60% | $140.76M | $100.34B | -3.41% | 80 Outperform | |
| Resmed | 4.52% | $138.31M | $30.44B | -14.87% | 76 Outperform | |
| GE Healthcare Technologies Inc | 4.32% | $132.26M | $29.23B | -7.36% | 78 Outperform | |
| Boston Scientific | 4.14% | $126.66M | $84.23B | -45.31% | 79 Outperform |
IHI Technical Analysis
Neutral
―
Price Trends
52.32
Negative
56.13
Negative
58.78
Negative
Market Momentum
-0.72
Negative
48.37
Neutral
89.99
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IHI, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 49.96, equal to the 50-day MA of 52.32, and equal to the 200-day MA of 58.78, indicating a neutral trend. The MACD of -0.72 indicates Negative momentum. The RSI at 48.37 is Neutral, neither overbought nor oversold. The STOCH value of 89.99 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IHI.
IHI Peer Comparison
Comparison Results
Performance Comparison
IHI
iShares U.S. Medical Devices ETF
50.57
-11.10
-18.00%
IBB
iShares Biotechnology ETF
―
―
―
XBI
SPDR S&P BIOTECH ETF
―
―
―
FHLC
Fidelity MSCI Health Care Index ETF
―
―
―
IYH
iShares U.S. Healthcare ETF
―
―
―
FBT
First Trust NYSE Arca Biotechnology Index Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents